Company intelligence / Profile preview

Telepathic Technologies

Ownership: Private
Development stage: Preclinical

Overview

Telepathic Technologies has developed a non-invasive BCI using fNIRS that can identify individual words in the brain with up to 75% accuracy. The system is designed for real-time monitoring, offering applications in healthcare diagnostics, cognitive performance optimization, security authentication, and wearable tech. Their approach aims to be more affordable and accessible than EEG or MRI-based systems. No published large-scale clinical trial results yet.

Therapeutic areas: OtherNeurology
Modalities: DeviceBrain-computer interface (BCI)Non-invasive neurotechnology
Industry: Physiological Monitoring

Partnerships

Not specified as of June 2025.

Beyond the preview

Go deeper on Telepathic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telepathic Technologies.

Explore the full profile